According to this study, over the next five years the Pertussis Vaccine market will register a 0.7% CAGR in terms of revenue, the global market size will reach $ 7179.9 million by 2025, from $ 6980.9 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Pertussis Vaccine business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Pertussis Vaccine market by type, application, key manufacturers and key regions and countries.
This study considers the Pertussis Vaccine value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Whole-cell vaccines
Acellular vaccines
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Children
Adults
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Sanofi Pasteur
GSK
Astellas Pharma
Minhai Biotechnology
Mitsubishi Tanabe Pharma
Wuhan Institute of Biological Products
Changchun Changsheng Life Sciences
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Pertussis Vaccine consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Pertussis Vaccine market by identifying its various subsegments.
Focuses on the key global Pertussis Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pertussis Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Pertussis Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pertussis Vaccine Consumption 2015-2025
2.1.2 Pertussis Vaccine Consumption CAGR by Region
2.2 Pertussis Vaccine Segment by Type
2.2.1 Whole-cell vaccines
2.2.2 Acellular vaccines
2.3 Pertussis Vaccine Consumption by Type
2.3.1 Global Pertussis Vaccine Consumption Market Share by Type (2015-2020)
2.3.2 Global Pertussis Vaccine Revenue and Market Share by Type (2015-2020)
2.3.3 Global Pertussis Vaccine Sale Price by Type (2015-2020)
2.4 Pertussis Vaccine Segment by Application
2.4.1 Children
2.4.2 Adults
2.5 Pertussis Vaccine Consumption by Application
2.5.1 Global Pertussis Vaccine Consumption Market Share by Type (2015-2020)
2.5.2 Global Pertussis Vaccine Value and Market Share by Type (2015-2020)
2.5.3 Global Pertussis Vaccine Sale Price by Type (2015-2020)
3 Global Pertussis Vaccine by Company
3.1 Global Pertussis Vaccine Sales Market Share by Company
3.1.1 Global Pertussis Vaccine Sales by Company (2018-2020)
3.1.2 Global Pertussis Vaccine Sales Market Share by Company (2018-2020)
3.2 Global Pertussis Vaccine Revenue Market Share by Company
3.2.1 Global Pertussis Vaccine Revenue by Company (2018-2020)
3.2.2 Global Pertussis Vaccine Revenue Market Share by Company (2018-2020)
3.3 Global Pertussis Vaccine Sale Price by Company
3.4 Global Pertussis Vaccine Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Pertussis Vaccine Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Pertussis Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Pertussis Vaccine by Regions
4.1 Pertussis Vaccine by Regions
4.2 Americas Pertussis Vaccine Consumption Growth
4.3 APAC Pertussis Vaccine Consumption Growth
4.4 Europe Pertussis Vaccine Consumption Growth
4.5 Middle East & Africa Pertussis Vaccine Consumption Growth
5 Americas
5.1 Americas Pertussis Vaccine Consumption by Countries
5.1.1 Americas Pertussis Vaccine Consumption by Countries (2015-2020)
5.1.2 Americas Pertussis Vaccine Value by Countries (2015-2020)
5.2 Americas Pertussis Vaccine Consumption by Type
5.3 Americas Pertussis Vaccine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Pertussis Vaccine Consumption by Regions
6.1.1 APAC Pertussis Vaccine Consumption by Regions (2015-2020)
6.1.2 APAC Pertussis Vaccine Value by Regions (2015-2020)
6.2 APAC Pertussis Vaccine Consumption by Type
6.3 APAC Pertussis Vaccine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Pertussis Vaccine by Countries
7.1.1 Europe Pertussis Vaccine Consumption by Countries (2015-2020)
7.1.2 Europe Pertussis Vaccine Value by Countries (2015-2020)
7.2 Europe Pertussis Vaccine Consumption by Type
7.3 Europe Pertussis Vaccine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Pertussis Vaccine by Countries
8.1.1 Middle East & Africa Pertussis Vaccine Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Pertussis Vaccine Value by Countries (2015-2020)
8.2 Middle East & Africa Pertussis Vaccine Consumption by Type
8.3 Middle East & Africa Pertussis Vaccine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Pertussis Vaccine Distributors
10.3 Pertussis Vaccine Customer
11 Global Pertussis Vaccine Market Forecast
11.1 Global Pertussis Vaccine Consumption Forecast (2021-2025)
11.2 Global Pertussis Vaccine Forecast by Regions
11.2.1 Global Pertussis Vaccine Forecast by Regions (2021-2025)
11.2.2 Global Pertussis Vaccine Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Pertussis Vaccine Forecast by Type
11.8 Global Pertussis Vaccine Forecast by Application
12 Key Players Analysis
12.1 Sanofi Pasteur
12.1.1 Company Information
12.1.2 Pertussis Vaccine Product Offered
12.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Sanofi Pasteur Latest Developments
12.2 GSK
12.2.1 Company Information
12.2.2 Pertussis Vaccine Product Offered
12.2.3 GSK Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 GSK Latest Developments
12.3 Astellas Pharma
12.3.1 Company Information
12.3.2 Pertussis Vaccine Product Offered
12.3.3 Astellas Pharma Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Astellas Pharma Latest Developments
12.4 Minhai Biotechnology
12.4.1 Company Information
12.4.2 Pertussis Vaccine Product Offered
12.4.3 Minhai Biotechnology Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Minhai Biotechnology Latest Developments
12.5 Mitsubishi Tanabe Pharma
12.5.1 Company Information
12.5.2 Pertussis Vaccine Product Offered
12.5.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Mitsubishi Tanabe Pharma Latest Developments
12.6 Wuhan Institute of Biological Products
12.6.1 Company Information
12.6.2 Pertussis Vaccine Product Offered
12.6.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Wuhan Institute of Biological Products Latest Developments
12.7 Changchun Changsheng Life Sciences
12.7.1 Company Information
12.7.2 Pertussis Vaccine Product Offered
12.7.3 Changchun Changsheng Life Sciences Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Changchun Changsheng Life Sciences Latest Developments
...
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Pertussis Vaccine Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of W